Proximity-inducing modalities: the past, present, and future

S Singh, W Tian, ZC Severance… - Chemical Society …, 2023 - pubs.rsc.org
Living systems use proximity to regulate biochemical processes. Inspired by this
phenomenon, bifunctional modalities that induce proximity have been developed to redirect …

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

GM Van Dam, G Themelis, LMA Crane, NJ Harlaar… - Nature medicine, 2011 - nature.com
The prognosis in advanced-stage ovarian cancer remains poor. Tumor-specific
intraoperative fluorescence imaging may improve staging and debulking efforts in …

Prospects in folate receptor-targeted radionuclide therapy

C Müller, R Schibli - Frontiers in oncology, 2013 - frontiersin.org
Targeted radionuclide therapy is based on systemic application of particle-emitting
radiopharmaceuticals which are directed toward a specific tumor-associated target …

Redirection of genetically engineered CAR-T cells using bifunctional small molecules

MS Kim, JSY Ma, H Yun, Y Cao, JY Kim… - Journal of the …, 2015 - ACS Publications
Chimeric antigen receptor (CAR)-engineered T cells (CAR-Ts) provide a potent antitumor
response and have become a promising treatment option for cancer. However, despite their …

Peptidic chimeric antigen receptor T cell switches and uses thereof

T Young, C Kim, PG Schultz - US Patent 9,624,276, 2017 - Google Patents
C07K I4/00(2006.01) US Appl. No. 14/432,065, Travis Young. C07K 6/00(2006.01) AXup, J.
et al., Synthesis of site-specific antibody-drug conjugates A6 IK 39/00(2006.01) using …

Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators

CE Jakobsche, CG Parker, RN Tao… - ACS chemical …, 2013 - ACS Publications
The ability to profile the prevalence and functional activity of endogenous antibodies is of
vast clinical and diagnostic importance. Serum antibodies are an important class of …

Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation

C Muller - Current pharmaceutical design, 2012 - ingentaconnect.com
Frequent overexpression of the folate receptor (FR) on a variety of tumor types and on
activated macrophages makes this re-ceptor an interesting target for both imaging and …

“Click and go”: simple and fast folic acid conjugation

AF Trindade, RFM Frade, EMS Maçôas… - Organic & …, 2014 - pubs.rsc.org
Folic acid targeting by functionalization of the terminal γ-carboxylic acid is one of the most
important strategies to selectively deliver chemotherapeutics and dyes to cancer cells which …

Photoswitchable CAR-T cell function in vitro and in vivo via a cleavable mediator

B Zhang, Y Wang, S Huang, J Sun, M Wang, W Ma… - Cell Chemical …, 2021 - cell.com
Chimeric antigen receptor (CAR)-T-based therapeutics are a breakthrough in cancer
treatment; however, they are hampered by constitutive activation, which leads to worrisome …

A phase I study of folate immune therapy (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) in patients with renal cell carcinoma

RJ Amato, A Shetty, Y Lu, R Ellis… - Journal of …, 2013 - journals.lww.com
This is the first phase I, open-label study to assess the safety, pharmacokinetics, and
antitumor activity of a novel immunotherapeutic regimen known as Folate Immune (EC90 …